{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00566657: Phase 3 Interventional Completed Peripheral Vascular Diseases
(2007)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:mavilimogene ralaplasmid [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00711997: Phase 1/Phase 2 Interventional Completed Pancreatic Neoplasms
(2009)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:pixofisiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01188785: Phase 1 Interventional Completed Pancreatic Ductal Adenocarcinoma
(2011)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:tirvalimogene teraplasmid [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04549922: Phase 2 Interventional Completed Covid19
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID